IL288239A - Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices - Google Patents

Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Info

Publication number
IL288239A
IL288239A IL288239A IL28823921A IL288239A IL 288239 A IL288239 A IL 288239A IL 288239 A IL288239 A IL 288239A IL 28823921 A IL28823921 A IL 28823921A IL 288239 A IL288239 A IL 288239A
Authority
IL
Israel
Prior art keywords
preventing
formation
biological matrices
calcified deposits
xenoantigens
Prior art date
Application number
IL288239A
Other languages
Hebrew (he)
Original Assignee
Biocompatibility Innovation Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibility Innovation Srl filed Critical Biocompatibility Innovation Srl
Publication of IL288239A publication Critical patent/IL288239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
IL288239A 2019-05-22 2021-11-18 Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices IL288239A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201900007094 2019-05-22
PCT/IB2020/054885 WO2020234845A1 (en) 2019-05-22 2020-05-22 Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Publications (1)

Publication Number Publication Date
IL288239A true IL288239A (en) 2022-01-01

Family

ID=67734776

Family Applications (1)

Application Number Title Priority Date Filing Date
IL288239A IL288239A (en) 2019-05-22 2021-11-18 Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Country Status (11)

Country Link
EP (1) EP3972659A1 (en)
JP (1) JP2022534228A (en)
KR (1) KR20220016119A (en)
CN (1) CN113874052A (en)
AU (1) AU2020277763A1 (en)
BR (1) BR112021023413A2 (en)
CA (1) CA3138296A1 (en)
IL (1) IL288239A (en)
MX (1) MX2021014295A (en)
WO (1) WO2020234845A1 (en)
ZA (1) ZA202109172B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113984820B (en) * 2021-08-31 2023-05-05 中南大学湘雅二医院 Reagent combination and method for improving calcification resistance of bovine pericardial valve material
CN118105544A (en) * 2022-11-30 2024-05-31 上海微创心通医疗科技有限公司 Biological tissue material and preparation method and application thereof
CN116019980A (en) * 2022-12-30 2023-04-28 四川大学 Functional cross-linked biological valve and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509168A (en) 1999-09-22 2003-03-11 バクスター・インターナショナル・インコーポレイテッド Heart valve and biological tissue preparation method
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
CN100360190C (en) * 2005-11-30 2008-01-09 中国科学院上海硅酸盐研究所 Method for preparing artificial biological valve with biological activity
CN101161293A (en) * 2006-10-12 2008-04-16 胡盛寿 Resist calcification modified method of heterogeneity biological organization material
ITPD20120029A1 (en) 2012-02-09 2013-08-10 Alessandro Gandaglia METHOD FOR DETECTION OF ONE XENOANTIGEN IN FIXED FABRICS USED AS BIO-PROSTHETIC SUBSTITUTES
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
ITUB20156019A1 (en) * 2015-11-30 2017-05-30 Biocompatibility Innovation Soc A Responsabilita Limitata Semplificata METHOD FOR THE INACTIVATION OF XENOANTIGENES IN BIOLOGICAL FABRICS
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment
CN107349215A (en) * 2017-08-30 2017-11-17 江南大学 Application of the Vaccarin in anti-angiogenic calcification medicine is prepared
CN108498869B (en) * 2018-04-08 2020-12-25 中国医学科学院生物医学工程研究所 Polyphenol crosslinking agent and application thereof in preparation of anti-calcification biological valve

Also Published As

Publication number Publication date
JP2022534228A (en) 2022-07-28
AU2020277763A1 (en) 2021-12-16
CN113874052A (en) 2021-12-31
KR20220016119A (en) 2022-02-08
ZA202109172B (en) 2024-05-30
EP3972659A1 (en) 2022-03-30
CA3138296A1 (en) 2020-11-26
BR112021023413A2 (en) 2022-01-04
WO2020234845A1 (en) 2020-11-26
MX2021014295A (en) 2022-01-06

Similar Documents

Publication Publication Date Title
IL288239A (en) Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices
IL282600A (en) Composition and method for treating the lungs
SG11202011080QA (en) Methods and compositions for treating cancer
IL275626A (en) Surface treatment compositions and methods
IL279748A (en) Composition and method for treating pain
ZA202101362B (en) Compositions and methods for treating the eye
SG11202012070YA (en) Methods and compositions for preventing or treating tissue calcification
IL285886A (en) Compositions and methods for treating laminopathies
ZA202101342B (en) Compositions and methods for treating the eye
IL280348A (en) Surface treatment compositions and methods
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
IL290348B1 (en) Surface treatment compositions and methods
PT3807316T (en) Compositions and methods for treating cancer
IL288010A (en) Antagonists of the complement system for use in methods of treating paraproteinemic neuropathies
IL280816A (en) Water treatment methods and apparatus
IL281394A (en) Method and composition for preventing and treating atherosclerosis and related diseases
IL290656A (en) Lurbinectedin in the treatment of malignant mesothelioma
IL285796A (en) Methods and compositions for treating
ZA202101360B (en) Compositions and methods for treating the eye
ZA202101361B (en) Compositions and methods for treating the eye
GB202001422D0 (en) Compositions and methods for preventing or treating nephrolithiasis
ZA202007183B (en) Compositions and methods for treating the eye
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
SG11202010911WA (en) Methods and compositions for treating chronic urticaria